The Pennant Group, Inc. (NASDAQ:PNTG) Stock Has Consensus Price Target of $41.60

The Pennant Group, Inc. (NASDAQ:PNTG) has earned a consensus rating of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year target price among analysts that have covered the stock in the last year is $42.00.

A number of brokerages recently weighed in on PNTG. Royal Bank Of Canada upped their target price on shares of The Pennant Group from $42.00 to $44.00 and gave the stock an “outperform” rating in a research note on Thursday, August 20th. Wells Fargo & Company lifted their price target on The Pennant Group from $45.00 to $46.00 and gave the company an “overweight” rating in a research note on Tuesday, August 11th. Truist Financial boosted their price target on The Pennant Group from $42.00 to $48.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Wall Street Zen raised The Pennant Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. Finally, Weiss Ratings raised The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, August 19th.

Hedge Funds Weigh In On The Pennant Group

Large investors have recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of The Pennant Group in the second quarter valued at approximately $109,340,000. Wasatch Advisors LP lifted its position in shares of The Pennant Group by 31.8% in the second quarter. Wasatch Advisors LP now owns 1,870,178 shares of the company’s stock worth $69,103,000 after purchasing an additional 451,491 shares in the last quarter. Paradigm Capital Management Inc. NY acquired a new position in The Pennant Group during the second quarter worth $51,833,000. Turtle Creek Asset Management Inc. boosted its holdings in The Pennant Group by 12,075.6% during the first quarter. Turtle Creek Asset Management Inc. now owns 1,582,823 shares of the company’s stock worth $48,244,000 after purchasing an additional 1,569,823 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in The Pennant Group by 1.5% in the first quarter. Dimensional Fund Advisors LP now owns 815,660 shares of the company’s stock valued at $24,861,000 after purchasing an additional 11,943 shares in the last quarter. Institutional investors and hedge funds own 85.88% of the company’s stock.

The Pennant Group Stock Performance

Shares of PNTG stock opened at $39.73 on Thursday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.20 and a current ratio of 1.20. The Pennant Group has a 52 week low of $22.25 and a 52 week high of $42.74. The company’s 50 day moving average price is $39.18 and its two-hundred day moving average price is $36.09. The company has a market capitalization of $1.39 billion, a P/E ratio of 44.14, a price-to-earnings-growth ratio of 2.59 and a beta of 1.25.

The Pennant Group (NASDAQ:PNTG) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.03. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%. The company had revenue of $297.98 million during the quarter, compared to analysts’ expectations of $288.71 million. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. On average, analysts expect that The Pennant Group will post 1.18 earnings per share for the current fiscal year.

About The Pennant Group

The Pennant Group, Inc (NASDAQ:PNTG) is a healthcare services company that operates businesses focused on home-based care and senior living. Through its affiliated companies, Pennant provides home health, hospice and personal care services, as well as residential senior living services for older adults with varying care needs.

Its home health operations offer clinical care and rehabilitation services in patients’ homes, while its hospice businesses provide comfort-focused care and support for individuals with advanced illnesses and their families.